Predictive Diagnosis of Neurological Function in Patients with Atherosclerotic Cerebral Arterial Stenosis by Transcranial Doppler Ultrasound Imaging Information Technology

Objective: The purpose of this experiment is to observe the clinical effect of transcranial ultrasound thrombolytic adjuvant therapy, and to provide clinical results for transcranial ultrasound thrombolytic therapy for atherosclerotic cerebral arterial stenosis. in accordance with. Methods: Collected in the Department of Neurology, Brain Hospital of our hospital within 24 hours after the onset from October 2012 to April 2014, DSA and/or MRA, CTA examination confirmed the existence of middle cerebral artery stenosis and evidence of cerebral atherosclerosis, 100 patients with narrow middle cerebral artery as the diagnostic criteria for cerebral infarction. Results: The positive rates of microemboli in the ultrasound thrombolysis group at 7 days and 14 days were 17.00% and 6.00% significantly lower than those in the drug treatment group at 67.00% and 8.30% (P < 0.05); the 7 days and 14 days of ultrasound thrombolysis treatment group Serum high-sensitivity (P < 0.05), and serum C-reactive protein levels in the ultrasound thrombolytic treatment group were significantly lower than those in the drug treatment group (P < 0.05). Conclusion: Transcranial ultrasound thrombolytic adjuvant drug treatment can significantly promote the recovery of neurological function.